Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX

Prog Clin Biol Res. 1990:324:69-78.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adsorption
  • Adult
  • Aged
  • Blood Coagulation Factors / antagonists & inhibitors
  • Blood Coagulation Factors / therapeutic use*
  • Child
  • Child, Preschool
  • Cyclophosphamide / therapeutic use*
  • Drug Therapy, Combination
  • Factor IX / antagonists & inhibitors
  • Factor IX / immunology
  • Factor IX / therapeutic use
  • Factor VIII / antagonists & inhibitors
  • Factor VIII / immunology
  • Factor VIII / therapeutic use
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology
  • Hemophilia B / drug therapy*
  • Hemophilia B / immunology
  • Humans
  • Immune Tolerance / drug effects*
  • Immunoglobulin G / therapeutic use*
  • Injections, Intravenous
  • Middle Aged
  • Staphylococcal Protein A

Substances

  • Blood Coagulation Factors
  • Immunoglobulin G
  • Staphylococcal Protein A
  • Cyclophosphamide
  • Factor VIII
  • Factor IX